3'-UTR SEQUENCES FOR RNA STABILIZATION Russian patent published in 2022 - IPC C12N15/113 C12N15/67 C12N15/90 

Abstract RU 2783165 C1

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology, in particular to a nucleic acid molecule containing in the direction of transcription 5' → 3': (a) a promoter, (b) a transcribed nucleic acid sequence or a nucleic acid sequence for introducing a transcribed nucleic acid sequence, and (c) a nucleic acid sequence an acid which, when transcribed under the control of promoter (a), encodes a 3' untranslated region of the transcript that is not naturally associated with the nucleic acid (b). Also disclosed is a method for producing RNA, involving the use of the above molecule, as well as a method for producing a peptide or protein. The invention also relates to the use of the above RNA in a method for reprogramming somatic cells into cells for transfection of a host cell, as well as for vaccination.

EFFECT: invention is effective for improving the stability and efficiency of translation.

34 cl, 14 dwg, 18 tbl, 12 ex

Similar patents RU2783165C1

Title Year Author Number
SEQUENCE 3'-UTR FOR RNA STABILIZATION 2016
  • Orlandini Von Niessen, Alexandra
  • Fesser, Stephanie
  • Vallazza, Britta
  • Beissert, Tim
  • Kuhn, Andreas
  • Sahin, Ugur
  • Poleganov, Marco Alexander
RU2720934C2
ARTIFICIAL MOLECULES OF NUCLEIC ACID 2014
  • Tess Andreas
RU2717986C2
DEEP GLYCATION END PRODUCTS RECEPTOR MODULATORS AND MODULATION 2020
  • Uilton, Stiven
  • Tomas, Merlin Kristofer
  • Rozado, Karlos
  • Pikering, Raelen Dzhejn
RU2820247C2
ANTIGENE PEPTIDES FOR CANCER PREVENTION AND TREATMENT 2019
  • Chene Laurent
  • Bonny Christophe
  • Strozzi Francesco
RU2812911C2
HSD17B13 OPTIONS AND THEIR APPLICATIONS 2018
  • Abul-Husn, Noura, S.
  • Gottesman, Omri
  • Li, Alexander
  • Cheng, Xiping
  • Xin, Yurong
  • Pefanis, Evangelos
  • Hartford, Suzanne
  • Gromada, Jesper
  • Dewey, Frederick, E.
  • Baras, Aris
  • Shuldiner, Alan
RU2760851C2
CRISPR-CAS SYSTEMS AND METHODS FOR CHANGING THE EXPRESSION OF GENE PRODUCTS 2013
  • Zhang, Feng
RU2796273C2
PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS OF TREATING TUMORS 2019
  • Chen, Syaotsin
  • Chzhou, Syujsha
  • Rojzman, Bernard
  • Chzhou, Grejs Goin
RU2810906C2
METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICIENCY OF TREATMENT OF ONCOLOGICAL DISEASES AND PREDICTION OF ONCOLOGICAL DISEASES 2016
  • Sakhin Ugur
  • Tyurechi Ozlem
  • Maurus Daniel
RU2785291C2
AGENT FOR INHIBITION OF REPLICATION OF SARS-COV-2 VIRUS MEDIATED BY RNA INTERFERENCE 2020
  • Khaitov Musa Rakhimovich
  • Shilovskij Igor Petrovich
  • Kofiadi Ilya Andreevich
  • Sergeev Ilya Viktorovich
  • Kozlov Ivan Borisovich
  • Smirnov Valerij Valerevich
  • Kozhikhova Kseniya Vadimovna
  • Koloskova Olesya Olegovna
  • Andreev Sergej Mikhajlovich
  • Zhernov Yurij Vladimirovich
  • Nikonova Aleksandra Aleksandrovna
RU2733361C1
MODIFIED IMMUNOREGULATORY ELEMENT AND IMMUNITY CHANGE BY THIS ELEMENT 2017
  • Kim, Seok Joong
  • Kim, Yoon-Young
  • Yu, Ho-Sung
  • Jung, In-Young
  • Lee, Jung Min
RU2767206C2

RU 2 783 165 C1

Authors

Orlandini Fon Nissen, Aleksandra

Fesser, Shtefani

Vallatstsa, Britta

Bajssert, Tim

Kun, Andreas

Zakhin, Ugur

Poleganov, Marko Aleksandr

Dates

2022-11-09Published

2016-10-05Filed